|
Rheumatoid Arthritis
Citations 31-40 of 841 total displayed.
|
Past content
(since Feb 2000):
|
- CLINICAL
Validity of physician-reported hospitalized infections in a US arthritis registry
- Jeffrey R. Curtis, Nivedita M. Patkar, Archana Jain, Jeffrey Greenberg, and Daniel H. Solomon
Rheumatology 2009; 48: 1269-1272.
[Abstract]
[Full Text]
- CLINICAL
The effect of etanercept on work productivity in patients with early active rheumatoid arthritis: results from the COMET study
- Aslam Anis, Wei Zhang, Paul Emery, Huiying Sun, Amitabh Singh, Bruce Freundlich, and Reiko Sato
Rheumatology 2009; 48: 1283-1289.
[Abstract]
[Full Text]
- CLINICAL
Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies
- Christophe Meune, Emmanuel Touzé, Ludovic Trinquart, and Yannick Allanore
Rheumatology 2009; 48: 1309-1313.
[Abstract]
[Full Text]
- CLINICAL
Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity
- Kimme L. Hyrich, Chris Deighton, Kath D. Watson, BSRBR Control Centre Consortium, Deborah P. M. Symmons, and Mark Lunt on behalf of the British Society for Rheumatology Biologics Register
Rheumatology 2009; 48: 1323-1327.
[Abstract]
[Full Text]
- CASE REPORTS
Disseminated tuberculosis in a patient with idiopathic CD4+ lymphocytopenia
- Jan Thoden, Nils Venhoff, Michael Daskalakis, Annette Schmitt-Gräeff, Ruth Dräger, Michael Schlesier, Klaus Warnatz, and Hans-Hartmut Peter
Rheumatology 2009; 48: 1329-1330.
[Extract]
[Full Text]
- CASE REPORTS
Tuberculosis of the greater trochanter
- Ittimade Nassar and Farida Imani
Rheumatology 2009; 48: 1330-1331.
[Extract]
[Full Text]
- MATTERS ARISING
Comment on: Screening for Mycobacterium tuberculosis prior to anti-TNF therapy—an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence
- Batsi Chikura, Veena Sadananda, and Muniba Usman-Saeed
Rheumatology 2009; 48: 1331-1332.
[Extract]
[Full Text]
- MATTERS ARISING
Comment on: Screening for Mycobacterium tuberculosis prior to anti-TNF therapy—an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence: reply
- John D. Pradeep, Gavin P. R. Clunie, Karl Gaffney, Nicholas J. Innes, Alan Brooksby, Pamela Bradley, and Atul Gulati
Rheumatology 2009; 48: 1332-a.
[Extract]
[Full Text]
- REVIEWS
Can rheumatoid arthritis responsiveness to methotrexate and biologics be predicted?
- Carine Bansard, Thierry Lequerré, Maryvonne Daveau, Olivier Boyer, Francois Tron, Jean-Philippe Salier, Olivier Vittecoq, and Xavier Le-Loët
Rheumatology 2009; 48: 1021-1028.
[Abstract]
[Full Text]
- CLINICAL
Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis
- Tetsuji Sawada, Shigeko Inokuma, Takeo Sato, Takeshi Otsuka, Yukihiko Saeki, Tsutomu Takeuchi, Takemasa Matsuda, Tamiko Takemura, and Akira Sagawa on behalf of the Study Committee for Leflunomide-induced Lung Injury, Japan College of Rheumatology
Rheumatology 2009; 48: 1069-1072.
[Abstract]
[Full Text]
|
|
